
## Major Catalysts Mentioned
**Devon Energy and Coterra Energy**
- Date: TBD
- Why it matters: The two companies are merging in an all-stock deal to create a major player in the shale oil sector, valued at $58 billion, potentially reshaping the competitive landscape.
- Stocks affected: **$DVN**, **$CTRA**
**Exelixis**
- Date: TBD
- Why it matters: The FDA has accepted an NDA for Exelixis' zanzalintinib, which could lead to a significant boost in sales from the colorectal cancer treatment if approved.
- Stocks affected: **$EXEL**
**Trump Media**
- Date: February 2026
- Why it matters: A record date has been set for the distribution of digital tokens, which could have implications for the company's valuation and investor interest.
- Stocks affected: **$TMTG**
**IDEXX Laboratories**
- Date: February 2, 2026
- Why it matters: The company faces challenges despite a reportedly strong earnings report, indicating investor sentiment may be shifting and could impact stock performance.
- Stocks affected: **$IDXX**
## Earnings on Deck
- **$DIS** - Reports: February 2026 - Key watch: Profitability and theme park performance amid rising costs.
## Economic Events
- **U.S. Jobs Data** - Date: TBD - Expected impact: Major influence on Fed’s policy decisions going forward, particularly with the appointment of Kevin Warsh as Fed chair.
## What's NOT Dated But Worth Tracking
- **Ripple's New Files** - Watch for: Market reactions to potential bullish developments for **$XRP**, particularly in relation to ongoing legal matters.
- **Healthcare REIT Advances** - Watch for: Developments in AI-driven medical technologies that may impact healthcare real estate investments.
## Highest Conviction Catalyst
- What: Merger between Devon Energy and Coterra Energy
- When: TBD
- Why it matters: This merger creates a large shale oil operator, which may lead to increased market share and operational efficiencies, affecting both companies' stocks and the broader energy sector.
- Trade idea: Consider potential long positions in **$DVN** and **$CTRA** based on anticipated growth and market consolidation benefits.
Replies (0)
No replies yet. Be the first to reply!
Please login to reply to this post.